Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dina Robaa

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
ACS Medicinal Chemistry Letters|March 18, 2022
Structure-Activity Relationship of Anti-<i>Mycobacterium abscessus</i> Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase InhibitorsAndreas Beuchel, Dina Robaa, Dereje A Negatu, et al.
European Journal of Medicinal Chemistry|June 5, 2020
Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1Ehab Ghazy, Patrik Zeyen, Daniel Herp, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 17, 2017
Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseasesLarissa L S Scholte, Marina M Mourão, Fabiano Sviatopolk-Mirsky Pais, et al.
Future Medicinal Chemistry|March 15, 2016
Substituted 2-(2-aminopyrimidin-4-yl)pyridine-4-carboxylates as potent inhibitors of JumonjiC domain-containing histone demethylasesMartin Roatsch, Dina Robaa, Martin Pippel, et al.
Molecules (Basel, Switzerland)|March 3, 2018
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro TestingConrad V Simoben, Dina Robaa, Alokta Chakrabarti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Preclinical Evaluation of Benzazepine-Based PET Radioligands (<i>R</i>)- and (<i>S</i>)-<sup>11</sup>C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ<sub>1</sub>-Receptor-Targeted PET ImagingAchi Haider, Adrienne Müller Herde, Stefanie D Krämer, et al.
International Journal of Molecular Sciences|July 27, 2022
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma ActivitySalma Darwish, Ehab Ghazy, Tino Heimburg, et al.
Chemmedchem|May 29, 2018
Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of SchistosomiasisTheresa Bayer, Alokta Chakrabarti, Julien Lancelot, et al.
Journal of Medicinal Chemistry|March 4, 2016
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of SchistosomiasisTino Heimburg, Alokta Chakrabarti, Julien Lancelot, et al.
European Journal of Medicinal Chemistry|December 17, 2017
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiationJohannes Schulz-Fincke, Mirjam Hau, Jessica Barth, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
ACS Medicinal Chemistry Letters|March 18, 2022
Structure-Activity Relationship of Anti-<i>Mycobacterium abscessus</i> Piperidine-4-carboxamides, a New Class of NBTI DNA Gyrase InhibitorsAndreas Beuchel, Dina Robaa, Dereje A Negatu, et al.
European Journal of Medicinal Chemistry|June 5, 2020
Design, synthesis, and biological evaluation of dual targeting inhibitors of histone deacetylase 6/8 and bromodomain BRPF1Ehab Ghazy, Patrik Zeyen, Daniel Herp, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|May 17, 2017
Evolutionary relationships among protein lysine deacetylases of parasites causing neglected diseasesLarissa L S Scholte, Marina M Mourão, Fabiano Sviatopolk-Mirsky Pais, et al.
Future Medicinal Chemistry|March 15, 2016
Substituted 2-(2-aminopyrimidin-4-yl)pyridine-4-carboxylates as potent inhibitors of JumonjiC domain-containing histone demethylasesMartin Roatsch, Dina Robaa, Martin Pippel, et al.
Molecules (Basel, Switzerland)|March 3, 2018
A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro TestingConrad V Simoben, Dina Robaa, Alokta Chakrabarti, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 2019
Preclinical Evaluation of Benzazepine-Based PET Radioligands (<i>R</i>)- and (<i>S</i>)-<sup>11</sup>C-Me-NB1 Reveals Distinct Enantiomeric Binding Patterns and a Tightrope Walk Between GluN2B- and σ<sub>1</sub>-Receptor-Targeted PET ImagingAchi Haider, Adrienne Müller Herde, Stefanie D Krämer, et al.
International Journal of Molecular Sciences|July 27, 2022
Design, Synthesis and Biological Characterization of Histone Deacetylase 8 (HDAC8) Proteolysis Targeting Chimeras (PROTACs) with Anti-Neuroblastoma ActivitySalma Darwish, Ehab Ghazy, Tino Heimburg, et al.
Chemmedchem|May 29, 2018
Synthesis, Crystallization Studies, and in vitro Characterization of Cinnamic Acid Derivatives as SmHDAC8 Inhibitors for the Treatment of SchistosomiasisTheresa Bayer, Alokta Chakrabarti, Julien Lancelot, et al.
Journal of Medicinal Chemistry|March 4, 2016
Structure-Based Design and Synthesis of Novel Inhibitors Targeting HDAC8 from Schistosoma mansoni for the Treatment of SchistosomiasisTino Heimburg, Alokta Chakrabarti, Julien Lancelot, et al.
European Journal of Medicinal Chemistry|December 17, 2017
Structure-activity studies on N-Substituted tranylcypromine derivatives lead to selective inhibitors of lysine specific demethylase 1 (LSD1) and potent inducers of leukemic cell differentiationJohannes Schulz-Fincke, Mirjam Hau, Jessica Barth, et al.
Pageof 8